NEW YORK (GenomeWeb) — A former software engineer and self-proclaimed "do-it-yourself" biologist who previously marketed an ultra-cheap thermal cycler for fellow amateur biologists has formed a new company to commercialize a similarly inexpensive quantitative PCR platform.
NEW YORK (GenomeWeb) ― Cambridge, Mass.-based Amplyus has launched a Kickstarter funding campaign intended to bring its miniPCR platform into full production and "open the world of DNA science to everyone, everywhere."
A pair of Bay Area entrepreneurs has designed an open-source thermal cycler that can be assembled from off-the-shelf components and costs around $500. They will soon ship the first several systems in kit form to early customers to assemble in their own workspaces.
In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.